ARCHIVES

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

This article is from The Cancer Letter archive.

Vol. 19 No. 13 | March 26, 1993

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

September 27, 2002

Health Organizations: ACS Statement Supports funding of Research On Human Stem cells

December 17, 1999

NIH closes Meeting of BSC Chairmen, Violation of Open Meetings Law Alleged

August 5, 1994

OMB Orders NCI to Cut 12 Percent Until Final budget Is Approved; Grants Being Renegotiated

December 4, 1981

Adding Aresenic To Therapy Improves APL Survival

July 27, 2007

NIH Funding Opportunity: Outstanding Investigator Award In Cancer Research Available

June 11, 2014